Concepedia

Nabanita Mukherjee

NM

Statistics

Publications

11

Citations

1.1K

H-Index

11

Active since

2011

Affiliations

University of Colorado Anschutz Medical Campus(Current)

Veterans Health Administration

St. Jude Children's Research Hospital

University of Memphis

Tennessee Department of Health

Nabanita Mukherjee is an author at University of Colorado Anschutz Medical Campus specializing in medicine, cell biology, and tumor biology.

ORCID

Top concepts

Publications per year

2011–2024

11

Publications

11

Gut Microbiome Metagenomics Analysis Suggests a Functional Model for the Development of Autoimmunity for Type 1 Diabetes

Christopher T. Brown, Austin G. Davis‐Richardson, Adriana Giongo et al. · PLoS ONE · 2011 · 772 citations · Full text

, , +20

MCL1 inhibitors S63845/MIK665 plus Navitoclax synergistically kill difficult-to-treat melanoma cells

Nabanita Mukherjee, Jenette Skees, Kaleb J. Todd et al. · Cell Death and Disease · 2020 · 70 citations · Full text

Use of a MCL-1 inhibitor alone to de-bulk melanoma and in combination to kill melanoma initiating cells

Nabanita Mukherjee, Yan Lü, Adam R. Almeida et al. · Oncotarget · 2016 · 34 citations · Full text

Combining a BCL2 Inhibitor with the Retinoid Derivative Fenretinide Targets Melanoma Cells Including Melanoma Initiating Cells

Nabanita Mukherjee, Steven N. Reuland, Yan Lü et al. · Journal of Investigative Dermatology · 2014 · 32 citations · Full text

, , +9

Simultaneously Inhibiting BCL2 and MCL1 Is a Therapeutic Option for Patients with Advanced Melanoma

Nabanita Mukherjee, Carol M. Amato, Jenette Skees et al. · Cancers · 2020 · 32 citations · Full text

, , +17

1–5 of 11